Alzheimer Disease

Showing NaN - NaN of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer Trial in United States (NPT088, Placebo)

Completed
  • Alzheimer Disease
  • Costa Mesa, California
  • +22 more
Aug 14, 2019

Alzheimer, Alzheimer, Late Onset Trial in Tampa (MemorEM 1000)

Completed
  • Alzheimer Disease
  • Alzheimer Disease, Late Onset
  • MemorEM 1000
  • Tampa, Florida
    Byrd Alzheimer's Institute, University of South Florida
Apr 22, 2019

Alzheimer, Cognition Disorders Trial in United States (florbetapir F 18 PET scan)

Completed
  • Alzheimer Disease
  • Cognition Disorders
  • florbetapir F 18 PET scan
  • Glendale, Arizona
  • +74 more
Oct 23, 2018

Alzheimer Trial in United States (Naproxen Sodium (Aleve), Celecoxib (Celebrex))

Completed
  • Alzheimer Disease
  • Naproxen Sodium (Aleve)
  • Celecoxib (Celebrex)
  • Sun City, Arizona
  • +5 more
Oct 18, 2016

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
  • Alzheimer Disease
  • Birmingham, Alabama
  • +286 more
May 3, 2016

Alzheimer Trial in Worldwide (Florbetaben (BAY94-9172))

Completed
  • Alzheimer Disease
  • Florbetaben (BAY94-9172)
  • Sun City, Arizona
  • +18 more
Apr 27, 2016

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
  • Alzheimer Disease
  • Birmingham, Alabama
  • +347 more
Dec 4, 2015

Alzheimer Trial in Worldwide (Bapineuzumab 0.5 mg/kg)

Terminated
  • Alzheimer Disease
  • Bapineuzumab 0.5 mg/kg
  • Birmingham, Alabama
  • +182 more
Nov 30, 2015

Alzheimer Trial in United States (Valproate, Placebo)

Completed
  • Alzheimer Disease
  • Sun City, Arizona
  • +45 more
Sep 15, 2014

Alzheimer Trial in Canada, United States (NS 2330 (Tesofensine))

Completed
  • Alzheimer Disease
  • NS 2330 (Tesofensine)
  • Mesa, Arizona
  • +86 more
Oct 28, 2013

Alzheimer Trial in Worldwide (Placebo, SAM-531 1.5 mg, SAM-531 3.0 mg)

Terminated
  • Alzheimer Disease
  • Placebo
  • +4 more
  • Phoenix, Arizona
  • +94 more
Dec 21, 2012

Down Syndrome, Alzheimer Trial in Worldwide (Vitamin E, multivitamin, Placebo)

Unknown status
  • Down Syndrome
  • Alzheimer Disease
  • Vitamin E
  • +2 more
  • Farmington, Connecticut
  • +21 more
May 2, 2012

Alzheimer Trial in United States (Rofecoxib, Naproxen)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +39 more
Dec 10, 2009

Alzheimer Trial in United States (Estrogen)

Completed
  • Alzheimer Disease
  • Birmingham, Alabama
  • +24 more
Dec 10, 2009

Alzheimer, Dementia Trial in United States (MPC-7869)

Completed
  • Alzheimer Disease
  • Dementia
  • Alabaster, Alabama
  • +132 more
May 3, 2009

Alzheimer Trial in Canada, United States (xaliproden (SR57746A))

Completed
  • Alzheimer Disease
  • xaliproden (SR57746A)
  • Birmingham, Alabama
  • +120 more
Aug 20, 2008

Alzheimer, Dementia Trial in Worldwide (MPC-7869)

Terminated
  • Alzheimer Disease
  • Dementia
  • Phoenix, Arizona
  • +91 more
Aug 1, 2008

Alzheimer Trial in United States (Huperzine A)

Completed
  • Alzheimer Disease
  • Huperzine A
  • Birmingham, Alabama
  • +28 more
Feb 19, 2008

Healthy Aging and Memory Study

Completed
  • Alzheimer Disease
    • Birmingham, Alabama
    • +38 more
    Sep 14, 2007

    Alzheimer Trial in Canada, United States (3APS)

    Unknown status
    • Alzheimer Disease
    • Peoria, Arizona
    • +66 more
    Feb 27, 2007

    Alzheimer Trial in United States (Prednisone)

    Completed
    • Alzheimer Disease
    • Birmingham, Alabama
    • +18 more
    Jun 23, 2005

    Alzheimer, Dyssomnias Trial in United States (Melatonin)

    Completed
    • Alzheimer Disease
    • Dyssomnias
    • Tucson, Arizona
    • +30 more
    Jun 23, 2005

    Alzheimer Trial in United States (Trazodone, Haloperidol)

    Completed
    • Alzheimer Disease
    • Los Angeles, California
    • +15 more
    Jun 23, 2005